Prothena Corporation PLC header image

Prothena Corporation PLC

PRTA

Equity

ISIN IE00B91XRN20 / Valor 20224443

NASDAQ (2026-02-20)

USD 9.02-0.11%

Prothena Corporation PLC
UMushroom community rating:

3.86 7 votes No rating yet

NegativeNeutralPositive

About company

Prothena Corporation PLC is a biotechnology firm focused on the late-stage clinical development of treatments for neurodegenerative and rare peripheral amyloid diseases. Leveraging its expertise in protein dysregulation, the company has developed a diverse pipeline of investigational therapies aimed at addressing the complex challenges of neurological dysfunction and misfolded proteins. Prothena's approach combines internal discovery with strategic collaborations across academia and the industry to advance its portfolio of novel therapeutic solutions. Founded from the legacy of Athena Neurosciences and established as an independent entity in December 2012, Prothena trades on the Nasdaq Global Select Market under the symbol "PRTA." The company's commitment to innovation is rooted in its history of significant scientific contributions, including discoveries that have advanced the understanding of Alzheimer’s disease and the development of FDA-approved treatments for multiple sclerosis.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-40.9%1Y

-83.1%3Y

-61.2%5Y

Performance

65.0%1Y

66.4%3Y

77.4%5Y

Volatility

486 M

Market cap (USD)

786,420

Daily traded volume (Shares)

15.25 / 14.66

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.86

7 votes

Performance:

3.00

Innovation:

4.00

Society:

4.00

Nature:

3.57

Daniel Bruggmann

Switzerland, 19 Apr 2025

hoffen

Daniel Bruggmann

Switzerland, 17 Apr 2025

warten

Daniel Bruggmann

Switzerland, 16 Apr 2025

abwarten

EQUITIES OF THE SAME SECTOR

Elmos Semiconductor SE

Elmos Semiconductor SE Valor: 810140

Annual Return

-50%0%+50%

Risk level

110

-0.31%EUR 127.20

GFT Technologies SE

GFT Technologies SE Valor: 970686

Annual Return

-50%0%+50%

Risk level

110

1.37%EUR 14.76

adesso SE

adesso SE Valor: 10467159

Annual Return

-50%0%+50%

Risk level

110

-2.37%EUR 61.80

Uber Technologies Inc

Uber Technologies Inc Valor: 47459333

Annual Return

-50%0%+50%

Risk level

110

1.26%USD 73.86

SUSS MicroTec SE

SUSS MicroTec SE Valor: 13673056

Annual Return

-50%0%+50%

Risk level

110

1.63%EUR 50.00

Haier Smart Home Co., Ltd.

Haier Smart Home Co., Ltd. Valor: 42271151

Annual Return

-50%0%+50%

Risk level

110

-0.12%EUR 2.00

IVU Traffic Technologies AG

IVU Traffic Technologies AG Valor: 1099895

Annual Return

-50%0%+50%

Risk level

110

-1.24%EUR 19.85

LPKF Laser & Electronics SE

LPKF Laser & Electronics SE Valor: 967495

Annual Return

-50%0%+50%

Risk level

110

1.64%EUR 7.43

init innovation in traffic systems SE

init innovation in traffic systems SE Valor: 1265285

Annual Return

-50%0%+50%

Risk level

110

-1.32%EUR 44.80

Oxford Instruments PLC

Oxford Instruments PLC Valor: 399430

Annual Return

-50%0%+50%

Risk level

110

0.76%GBP 26.35

SIX

FactSet

Clearbit

Logos provided by Clearbit